Australia markets closed

Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
55.52+1.53 (+2.83%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 7.27B
Enterprise value 6.66B
Trailing P/E 14.93
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.23
Price/book (mrq)2.15
Enterprise value/revenue 4.82
Enterprise value/EBITDA 12.19

Trading information

Stock price history

Beta (5Y monthly) 2.53
52-week change 3-41.70%
S&P500 52-week change 327.86%
52-week high 3104.61
52-week low 344.78
50-day moving average 361.11
200-day moving average 365.31

Share statistics

Avg vol (3-month) 31.97M
Avg vol (10-day) 32.71M
Shares outstanding 5134.65M
Implied shares outstanding 6137.57M
Float 870.48M
% held by insiders 135.59%
% held by institutions 121.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 40.91%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 30.93%
5-year average dividend yield 4N/A
Payout ratio 413.83%
Dividend date 3N/A
Ex-dividend date 424 May 2023
Last split factor 21.5:1
Last split date 325 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 34.99%
Operating margin (ttm)37.23%

Management effectiveness

Return on assets (ttm)8.18%
Return on equity (ttm)15.25%

Income statement

Revenue (ttm)1.38B
Revenue per share (ttm)10.33
Quarterly revenue growth (yoy)-9.90%
Gross profit (ttm)N/A
EBITDA 517.15M
Net income avi to common (ttm)483.69M
Diluted EPS (ttm)3.54
Quarterly earnings growth (yoy)-28.00%

Balance sheet

Total cash (mrq)750.49M
Total cash per share (mrq)5.61
Total debt (mrq)142.12M
Total debt/equity (mrq)4.21%
Current ratio (mrq)4.47
Book value per share (mrq)25.26

Cash flow statement

Operating cash flow (ttm)440.37M
Levered free cash flow (ttm)155.47M